CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
7.48
-0.17 (-2.22%)
At close: Apr 28, 2026, 4:00 PM EDT
7.48
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
CVRx, Inc. Revenue
In the year 2025, CVRx, Inc. had annual revenue of $56.65M with 10.45% growth. CVRx, Inc. had revenue of $16.02M in the quarter ending December 31, 2025, with 4.45% growth.
Revenue (ttm)
$56.65M
Revenue Growth
+10.45%
P/S Ratio
3.56
Revenue / Employee
$254,040
Employees
223
Market Cap
197.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| InfuSystem Holdings | 143.44M |
| Quanterix | 138.90M |
| Sight Sciences | 77.36M |
| Electromed | 68.86M |
| 908 Devices | 56.20M |
| Apyx Medical | 52.84M |
| SANUWAVE Health | 44.05M |
CVRX News
- 1 day ago - CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026 - GlobeNewsWire
- 8 days ago - CVRx Announces Nomination of Michael Dale for Election to the Board of Directors - GlobeNewsWire
- 19 days ago - CVRx, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 2 months ago - CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting - GlobeNewsWire
- 2 months ago - CVRx, Inc. Earnings Call Transcript: Q4 2025 - Transcripts
- 3 months ago - CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026 - GlobeNewsWire
- 3 months ago - CVRx Kicks Off One Of The Largest Heart Device Trials In History - Benzinga
- 3 months ago - CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population - GlobeNewsWire